1 suspended. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Suspended 1 |
Follow immunotoxin therapy: new trials by email Literature Review of immunotoxin therapy trials Research Report on immunotoxin therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma BL22 immunotoxin, antibody-drug conjugate therapy, immunotoxin therapy - Leukemia, Lymphoma | Phase 1 | Suspended | MedImmune LLC | 95 | 2004-01-01 | 2007-12-28 |
Burkitt Lymphoma (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Leukemia (1) · Lymphoma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
MedImmune LLC (1)
United States (1)